The FDA approved two new medications for Niemann-Pick disease type C that improve symptoms, showing the power of community advocacy. News Dec 19, 2024|3min read Sponsorship effect: how drug manufacturers bias clinical trials News Jan 22, 2025 ...
With a market cap of $14.54 billion and an estimated $1.98 billion in live cash, Incyte is well-positioned to support its pipeline of investigational therapies. The company has nine approved products on the market, and its revenue guidance stands at $919.03 million. Incyte’s lead ...
Another prostate cancer trial has hit its main goal, and yet the drug developer can’t immediately file for an FDA approval.
Notable Labs http://www.notablelabs.com W15 Notable Labs helps doctors find combinations of FDA approved treatments that brain cancer patients can use today Omniref W15 dead Omniref is a code-based reference, maintained by and for the programming community Open Listings https://www.openlist...
The FDA recently approved their innovation for use in human patients. “For us to appear on a list highlighting the most innovative Universities in the world is a big deal. Research and Innovation at the University of Nebraska continues to grow and produce new discoveries at a rapid pace, ...
If patients are taking antineoplastic, immunosuppressive, or immune-modulating therapies, or if there is a history of prior use of these drugs, consider possible unintended additive immunosuppressive effects before initiating treatment with GILENYA [see WARNINGS AND PRECAUTIONS and DRUG INTERACTIONS]. Vacci...
Salonpas Pain Relief Patch Large is the first and only FDA-approved OTC pain relieving patches, now double-sized! Salonpas Lidocaine Pain-Relieving Gel Patch provides numbing, unscented maximum strength pain relief available without a prescription. Salonpas Lidocaine Plus Pain Relieving Liquid provides...
Use of XELJANZ/XELJANZ XR in combination with biological therapies for UC or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended. Polyarticular Course Juvenile Idiopathic Arthritis XELJANZ/XELJANZ Oral Solution is indicated for the treatment of active polyarticular course...
FDA ApprovalThe latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing...
FDA ApprovalThe latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing...